Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
Comparative Effectiveness of Pharmacological Interventions (1 of 2)
When compared with tolterodine, fesoterodine achieves higher rates of continence (55 reports per 1,000 treated patients) and improvement (45 events per 1,000 treated patients).
The strength of evidence for findings about continence is low, and the strength of evidence for the finding about improvement is high.
No statistically significant difference in improvement rates is found in comparisons of oxybutynin and tolterodine. The strength of evidence for this finding is moderate.
- Shamliyan T, Wyman J, Sainfort F, et al. Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness. Comparative Effectiveness Review No. 36 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2007-10064-I). Rockville, MD: Agency for Healthcare Research and Quality; April 2012. AHRQ Publication No. 11(12)-EHC074-EF. Available at www.effectivehealthcare.ahrq.gov/ui.cfm.
Your slide tray is being processed.